These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12408742)

  • 1. BMP 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra. Bone morphogenetic protein 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra, INFUSE Bone Graft, recombinant human bone morphogenetic protein 2--Genetics Institute/Medtronic-Sofamor Danek/Integra, RhBMP 2--Genetics Institute/Medtronic-Sofamor Danek/Integra.
    BioDrugs; 2002; 16(5):376-7. PubMed ID: 12408742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human bone morphogenic protein-2-enhanced anterior spine fusion without bone encroachment into the spinal canal: a histomorphometric study in a thoracoscopically instrumented porcine model.
    Zhang H; Sucato DJ; Welch RD
    Spine (Phila Pa 1976); 2005 Mar; 30(5):512-8. PubMed ID: 15738782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
    Boyne PJ
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage.
    Boden SD; Martin GJ; Horton WC; Truss TL; Sandhu HS
    J Spinal Disord; 1998 Apr; 11(2):95-101. PubMed ID: 9588464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion.
    Glassman SD; Carreon LY; Campbell MJ; Johnson JR; Puno RM; Djurasovic M; Dimar JR
    Spine J; 2008; 8(3):443-8. PubMed ID: 17526436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft).
    McKay WF; Peckham SM; Badura JM
    Int Orthop; 2007 Dec; 31(6):729-34. PubMed ID: 17639384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2.
    Burkus JK; Dorchak JD; Sanders DL
    Spine (Phila Pa 1976); 2003 Feb; 28(4):372-7. PubMed ID: 12590213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.
    Shields LB; Raque GH; Glassman SD; Campbell M; Vitaz T; Harpring J; Shields CB
    Spine (Phila Pa 1976); 2006 Mar; 31(5):542-7. PubMed ID: 16508549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
    Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
    J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of bone morphogenetic protein-2 in mature adults: posterolateral non-instrument-assisted lumbar decompression and fusion.
    Hamilton DK; Jones-Quaidoo SM; Sansur C; Shaffrey CI; Oskouian R; Jane JA
    Surg Neurol; 2008 May; 69(5):457-61; discussion 461-2. PubMed ID: 18207557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.
    Burkus JK; Gornet MF; Schuler TC; Kleeman TJ; Zdeblick TA
    J Bone Joint Surg Am; 2009 May; 91(5):1181-9. PubMed ID: 19411467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Mummaneni PV; Pan J; Haid RW; Rodts GE
    J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion.
    Mulconrey DS; Bridwell KH; Flynn J; Cronen GA; Rose PS
    Spine (Phila Pa 1976); 2008 Sep; 33(20):2153-9. PubMed ID: 18725869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events reported after the use of recombinant human bone morphogenetic protein 2.
    Woo EJ
    J Oral Maxillofac Surg; 2012 Apr; 70(4):765-7. PubMed ID: 22177811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2.
    Villavicencio AT; Burneikiene S; Nelson EL; Bulsara KR; Favors M; Thramann J
    J Neurosurg Spine; 2005 Dec; 3(6):436-43. PubMed ID: 16381205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
    Singh K; Dumonski M; Stanley T; Ponnappan R; Phillips FM
    Spine (Phila Pa 1976); 2011 Feb; 36(3):192-6. PubMed ID: 20634780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
    Stambough JL; Clouse EK; Stambough JB
    Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.